Results 51 to 60 of about 738,883 (337)

Current evidence for treatment with nusinersen for spinal muscular atrophy : a systematic review [PDF]

open access: yes, 2019
Recent discovery of nusinersen, an antisense oligonucleotide drug, has provided encouragement for improving treatment of spinal muscular atrophy. No therapeutic options currently exist for this autosomal recessive motor neuron disorder.
Meylemans, Antoon, De Bleecker, Jan
core   +1 more source

CENTRAL ATROPHY [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1917
n ...
openaire   +1 more source

Genetic variants and magnetic resonance imaging measures in multiple sclerosis: a systematic review

open access: yesJournal of Medical Science, 2016
Introduction. Although environmental factors play the major role in the etiopathogenesis of multiple sclerosis (MS), genetic factors are implicated as well.
Jan Krzysztof Nowak   +7 more
doaj   +1 more source

Endoscopic Prediction for Acid Reflux in Patients without Hiatus Hernia

open access: yesThe Korean Journal of Gastroenterology, 2020
Background/Aims: A diagnosis of gastroesophageal reflux disease is challenging in patients who have reflux symptoms but do not respond to proton pump inhibitors nor have reflux esophagitis and hiatal hernia (HH) on endoscopy.
Jun Young Kim   +8 more
doaj   +1 more source

Atrophic Dermatofibrosarcoma Protuberans with Eosinophilic Infiltration

open access: yesDermatopathology, 2022
Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive spindle cell mesenchymal tumor arising in the dermis, with low metastatic potential.
Anber Mahboob   +3 more
doaj   +1 more source

Relationship between hippocampal structure and memory function in elderly humans [PDF]

open access: yes, 2006
With progressing age, the ability to recollect personal events declines, whereas familiarity-based memory remains relatively intact. It has been hypothesized that age-related hippocampal atrophy may contribute to this pattern because of its critical role
A. Szentkuti   +8 more
core   +1 more source

Dominant optic atrophy [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2012
DEFINITION OF THE DISEASE: Dominant Optic Atrophy (DOA) is a neuro-ophthalmic condition characterized by a bilateral degeneration of the optic nerves, causing insidious visual loss, typically starting during the first decade of life. The disease affects primary the retinal ganglion cells (RGC) and their axons forming the optic nerve, which transfer the
Dominique Bonneau   +11 more
openaire   +6 more sources

Type 2 Diabetes Mellitus May Exacerbate Gray Matter Atrophy in Patients With Early-Onset Mild Cognitive Impairment

open access: yesFrontiers in Neuroscience, 2020
BackgroundThe precise physiopathological association between the courses of neurodegeneration and cognitive decline in type 2 diabetes mellitus (T2DM) remains unclear.
Chang Li   +10 more
doaj   +1 more source

The anabolic steroid stanozolol is a potent inhibitor of human MutT homolog 1

open access: yesFEBS Letters, EarlyView.
MutT homolog 1 (MTH1) is a member of the NUDIX superfamily of enzymes and is an anticancer drug target. We show that stanozolol (Stz), an anabolic steroid, is an unexpected nanomolar inhibitor of MTH1. The X‐ray crystal structure of the human MTH1–Stz complex reveals a unique binding scaffold that could be utilized for future inhibitor development ...
Emma Scaletti Hutchinson   +7 more
wiley   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

open access: yesMolecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy